Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies

PURPOSE: To report the clinical features, severity, and management of ocular immune-related adverse events (irAEs) in the setting of immune checkpoint inhibitor therapy for metastatic malignancies. METHODS: Retrospective chart review at three tertiary ophthalmology clinics. Electronic medical record...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ocul Immunol Inflamm
Main Authors: Noble, Carl W, Gangaputra, Sapna S, Thompson, Ian A, Yuan, Amy, Apolo, Andrea B, Lee, Jung-Min, Papaliodis, George N, Kodati, Shilpa, Bishop, Rachel, Magone, M Teresa, Sobrin, Lucia, Sen, H Nida
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8130843/
https://ncbi.nlm.nih.gov/pubmed/31013173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/09273948.2019.1583347
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados